CVE-2024-58094

jfs: add check read-only before truncation in jfs_truncate_nolock()

Description

In the Linux kernel, the following vulnerability has been resolved: jfs: add check read-only before truncation in jfs_truncate_nolock() Added a check for "read-only" mode in the `jfs_truncate_nolock` function to avoid errors related to writing to a read-only filesystem. Call stack: block_write_begin() { jfs_write_failed() { jfs_truncate() { jfs_truncate_nolock() { txEnd() { ... log = JFS_SBI(tblk->sb)->log; // (log == NULL) If the `isReadOnly(ip)` condition is triggered in `jfs_truncate_nolock`, the function execution will stop, and no further data modification will occur. Instead, the `xtTruncate` function will be called with the "COMMIT_WMAP" flag, preventing modifications in "read-only" mode.

N/A
CVSS
Severity:
EPSS 0.03%
Affected: Linux Linux
Affected: Linux Linux
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-58094?
CVE-2024-58094 has not yet been assigned a CVSS score.
How to fix CVE-2024-58094?
To fix CVE-2024-58094, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-58094 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-58094 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-58094?
CVE-2024-58094 affects Linux Linux, Linux Linux.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.